Eventide Gilead Fund Ranked #1 Midcap Growth Fund by Lipper and the Wall Street Journal for the One-Year Period Ending November 30, 2012

BOSTON, MA--(Marketwire - Dec 18, 2012) - The Eventide Gilead Fund (NASDAQ: ETGLX), a mutual fund practicing values-based investing, was named ranked #1 in the Midcap Growth equity category, out of 39…

---

Allen Institute Moving to South Lake Union as Growth Continues

View the Slideshow Luke Timmerman The Allen Institute for Brain Science is in the midst of an audacious $300 million expansion, as it plans to grow to 350 employees, and recruit neuroscientists fro…

---

NeoGenomics, Inc. Reports 42% Test Volume Growth, 26% Revenue Growth and 22% Increase in Adjusted EBITDA for the Third Quarter 2012

FT. MYERS, Fla., Oct. 31, 2012 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC QB: NGNM), a leading provider of cancer genetic testing services today reported its results for the third quarter 2012.Third…

---

Bayer CropScience AG: Geared for Sustainable Growth

MONHEIM, Germany, Sept. 20, 2012 /PRNewswire/ -- Bayer CropScience has a robust strategy in place and is geared for continued strong growth over the mid-term, said CEO Sandra Peterson at the company'…

---